Change "varicella-zoster" to "herpes zoster."
This card is specifically referring to administering the Shingrix (a recominbinant zoster vaccine), which is safe to administer in patients with HIV regardless of CD4+ count per the CDC (https://www.cdc.gov/shingles/hcp/clinical-overview.html). AMBOSS also refers to the Shingrex vaccine as a recombinant zoster vaccine that protects against herpes zoster a.k.a. shingles (https://next.amboss.com/us/article/HR0Kof?q=herpes%20zoster#Ze87602b455db14f3b41d6d8de8b1731d). By using "varicella-zoster," it confuses the reader that this card may be referring to the Varivax vaccine.
Administration of Varivax (a varicella-zoster vaccine), is contraindicated in HIV patients with a CD4+ < 200 per the CDC (https://www.cdc.gov/vaccines/vpd/varicella/hcp/recommendations.html).